Viking Therapeutics (VKTX) Interest Expenses (2014 - 2015)
Viking Therapeutics' (VKTX) quarterly Interest Expenses came in at $35253.0 in Q1 2015, up 1268.52% year-over-year from $2576.0 in Q1 2014, and up 1268.52% quarter-over-quarter from $2576.0 in Q1 2014.
Viking Therapeutics (VKTX) Interest Expenses (2014 - 2015) Analysis & Trends
Viking Therapeutics has disclosed Interest Expenses across 2 years of filings, most recently posting $35253.0 for Q1 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | - |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | - |
| 10 | Viking Therapeutics | 4.86 Bn | 4.86 Bn | - | - |
Viking Therapeutics Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=VKTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();